Cambridge Healthtech Institute’s 10th International
Leaders in Biobanking Congress
Innovations to Maintain Integrity and Maximize Investment in Biospecimens
October 14-16, 2018
Today, biospecimen collections are used by multiple research groups for various aims, from basic research through clinical trials. Useful biosamples must be collected to maintain their molecular integrity for specific (or unknown) downstream analysis.
Thus, during research, biobanks are key infrastructures because at one time or another, these biospecimens have been stored in a biobank. Cambridge Healthtech Institute’s Tenth International Leaders in Biobanking Congress addresses
innovations in biospecimen science and infrastructure to support expanding applications. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate
the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.
Innovations covered include:
BIOSPECIMEN SCIENCE: MAINTAINING INTEGRITY
Preparing the Biospecimen
Collection
Processing
Isolation
Storage
Purification
Preservation
Case studies
Types of Biosamples
Legacy collections
Specialty collections
Biofluids
Fixed tissue
Frozen tissue
Donors
Disease indications
BIOBANKING MANAGEMENT: MAXIMIZING INVESTMENT
Resources
Scheduling and procurement
Collection and annotation
Specimen processing
Biopreservation protocols
Storage and backup
Requisition and withdrawal
Shipping and distribution
Automation
Informatics tools
Inventory control
Tracking and shipping
Databases
Infrastructure and hardware
LIMS
Data integration
Regulations
Chain of custody
Informed consent
Compliance
International harmony
HIPAA/CLIA/CAP
Hazardous specimens
Custodianship/Long-term storage
ADVANCING BIOMEDICAL RESEARCH: MULTIPLYING INVESTIGATIONS
Leveraging the Biospecimen
Biomarkers of health and disease
Translation from laboratory to clinic
Diagnostic tools
Targets for drug discovery
Tests for drug development
Clinical trials
Case studies
Using the Biospecimen
Extraction of biomolecules
Measuring quality
Fit-for-purpose
Assay development
Assay validation
Omics
Case studies
Those encouraged to submit a title and summary of their experiences for consideration of presentation include:
- Molecular researchers utilizing biospecimens for their research
- Biobankers providing biospecimens, developing biopreservation technologies standards and protocols, and managing resources while navigating regulatory compliance
- R&D researchers and clinical trial professionals collecting, analyzing, and utilizing data
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is April 6, 2018.
All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497
Email: mabrown@healthtech.com
For partnering and sponsorship information, please contact:
Katelin Fitzgerald
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com